83 related articles for article (PubMed ID: 9242440)
1. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors.
Goodison S; Yoshida K; Sugino T; Woodman A; Gorham H; Bolodeoku J; Kaufmann M; Tarin D
Cancer Res; 1997 Aug; 57(15):3140-4. PubMed ID: 9242440
[TBL] [Abstract][Full Text] [Related]
2. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors.
Yoshida K; Bolodeoku J; Sugino T; Goodison S; Matsumura Y; Warren BF; Toge T; Tahara E; Tarin D
Cancer Res; 1995 Oct; 55(19):4273-7. PubMed ID: 7545538
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 splice variants in colorectal cancer.
Wong LS; Cantrill JE; Morris AG; Fraser IA
Br J Surg; 1997 Mar; 84(3):363-7. PubMed ID: 9117309
[TBL] [Abstract][Full Text] [Related]
5. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
6. Semiquantitative Detection of Abnormal CD44 Transcripts in Colon Carcinomas by Reverse Transcription-Polymerase Chain Reaction Enzyme-linked Immunosorbant Assay (RT-PCR ELISA).
Yoshida K; Goodison S; Sugino T; Bolodeoku J; Churchman M; Warren BF; Tarin D
Mol Diagn; 1996 Sep; 1(3):167-173. PubMed ID: 10462557
[TBL] [Abstract][Full Text] [Related]
7. Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid.
Aogi K; Kitahara K; Urquidi V; Tarin D; Goodison S
Clin Cancer Res; 1999 Oct; 5(10):2790-7. PubMed ID: 10537343
[TBL] [Abstract][Full Text] [Related]
8. Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule.
Huerta S; Srivatsan ES; Venkatesan N; Peters J; Moatamed F; Renner S; Livingston EH
Surgery; 2001 Nov; 130(5):834-43. PubMed ID: 11685193
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression.
Hayes GM; Dougherty ST; Davis PD; Dougherty GJ
Cancer Gene Ther; 2004 Dec; 11(12):797-807. PubMed ID: 15359288
[TBL] [Abstract][Full Text] [Related]
11. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
[TBL] [Abstract][Full Text] [Related]
12. Changes in CD44 expression during carcinogenesis of the mouse colon.
Rudzki Z; LeDuy L; Jothy S
Exp Mol Pathol; 1997 Apr; 64(2):114-25. PubMed ID: 9316589
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
14. Combined detection of CD44 isoforms by exon-specific RT-PCR and immunohistochemistry in primary human brain tumors and brain metastases.
Frank S; Rihs HP; Stöcker W; Müller J; Dumont B; Baur X; Schackert HK; Schackert G
Biochem Biophys Res Commun; 1996 May; 222(3):794-801. PubMed ID: 8651925
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
[TBL] [Abstract][Full Text] [Related]
16. Effects of a synonymous variant in exon 9 of the CD44 gene on pre-mRNA splicing in a family with osteoporosis.
Vidal C; Cachia A; Xuereb-Anastasi A
Bone; 2009 Oct; 45(4):736-42. PubMed ID: 19580891
[TBL] [Abstract][Full Text] [Related]
17. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas.
Bloor BK; Rajarajan A; Jaafary-Haghighat K; Odell EW
Int J Oncol; 2002 Oct; 21(4):907-13. PubMed ID: 12239634
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
Liu NP; Roberts WL; Hale LP; Levesque MC; Patel DD; Lu CL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2027-37. PubMed ID: 9331266
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.
Kuniyasu H; Oue N; Tsutsumi M; Tahara E; Yasui W
Clin Cancer Res; 2001 Dec; 7(12):4067-72. PubMed ID: 11751503
[TBL] [Abstract][Full Text] [Related]
20. Novel CD44 messenger RNA isoforms in human thyroid and breast tissues feature unusual sequence rearrangements.
Ermak G; Jennings T; Boguniewicz A; Figge J
Clin Cancer Res; 1996 Aug; 2(8):1251-4. PubMed ID: 9816294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
